Contec Capital Expenditures from 2010 to 2024

300869 Stock   15.12  0.77  4.85%   
Contec Medical's Capital Expenditures is increasing over the years with slightly volatile fluctuation. Overall, Capital Expenditures is expected to go to about 41 M this year. From 2010 to 2024 Contec Medical Capital Expenditures quarterly data regression line had arithmetic mean of  37,601,756 and r-squared of  0.12. View All Fundamentals
 
Capital Expenditures  
First Reported
2019-09-30
Previous Quarter
6.6 M
Current Value
23.6 M
Quarterly Volatility
15.3 M
 
Covid
Check Contec Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Contec Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 15.9 M, Interest Expense of 47.4 M or Selling General Administrative of 10 M, as well as many indicators such as . Contec financial statements analysis is a perfect complement when working with Contec Medical Valuation or Volatility modules.
  
This module can also supplement various Contec Medical Technical models . Check out the analysis of Contec Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Contec Stock

Contec Medical financial ratios help investors to determine whether Contec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Contec with respect to the benefits of owning Contec Medical security.